You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly diagnosed MM patients

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Nantes, France
  • +3 more
Aug 16, 2022

Newly Diagnosed Multiple Myeloma Trial (Daratumumab)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • (no location specified)
Oct 10, 2021

Multiple Myeloma Trial in Cleveland (Palliative Care, FACT-MM questionnaire, HADS questionnaire)

Recruiting
  • Multiple Myeloma
  • Palliative Care
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023

Multiple Myeloma Trial in Denmark, Estonia, Norway (Selinexor 20 MG Oral Tablet, Bortezomib Injection, Lenalidomide capsule)

Recruiting
  • Multiple Myeloma
  • Selinexor 20 MG Oral Tablet
  • +3 more
  • Aalborg, Denmark
  • +10 more
Apr 22, 2022

Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Ann Arbor, Michigan
  • +3 more
Jan 19, 2023

Multiple Myeloma Trial in United States (Lenalidomide, Elotuzumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +6 more
Dec 17, 2021

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022

Myeloma, Multiple Trial in United States (Lenalidomide, Ixazomib, Daratumumab Injection)

Recruiting
  • Myeloma, Multiple
  • Bangor, Maine
  • +7 more
Mar 10, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 30, 2022

Plasma Cell Myeloma Trial in Worldwide (lenalidomide, bortezomib, cyclophosphamide)

Active, not recruiting
  • Plasma Cell Myeloma
  • Nantes Cedex 01, France
  • +11 more
May 3, 2022

Multiple Myeloma Trial in Suzhou (clarithromycin, lenalidomide, dexamethasone and autologous BCMA-directed CAR T-cells)

Recruiting
  • Multiple Myeloma
  • clarithromycin, lenalidomide, dexamethasone and autologous BCMA-directed CAR T-cells
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 22, 2021

Maintenance With Bortezomib Plus Daratumumab After Induction

Recruiting
  • Multiple Myeloma
  • Non-eligible for Autologous Stem Cell Transplantation (ASCT)
  • Arganda Del Rey, Spain
  • +31 more
Sep 15, 2022

Multiple Myeloma Prognostic Indices

Recruiting
  • Multiple Myeloma
  • Hematologic Diseases
  • blood viscosity , albumin / fibrinogen ratio and red cell distribution
  • Assiut, Egypt
    Assiut University hospital
Oct 17, 2023

Lenalidomide in Combination With Dexamethasone in Clinical

Active, not recruiting
  • Multiple Myeloma
    • Kirchdorf, Austria
    • +11 more
    May 16, 2022

    MULTIPLE MYELOMA (MM) Trial in Rionero in Vulture (Carfilzomib, Cyclophosphamide, Lenalidomide)

    Active, not recruiting
    • MULTIPLE MYELOMA (MM)
    • Rionero in Vulture, Italy
      IRCCS--CROB --CROB di Rionero in di Rionero in Vulture
    Apr 28, 2021

    Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Frailty
      • (no location specified)
      Oct 30, 2023

      Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

      Not yet recruiting
      • Prostate Cancer
      • Newly-Diagnosed Prostate Cancer
      • (no location specified)
      Nov 3, 2023

      Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

      Not yet recruiting
      • Multiple Myeloma
      • Renal Failure
      • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
      • Augusta, Georgia
        Georgia Cancer Center-Augusta University
      Nov 16, 2023

      Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

      Recruiting
      • Multiple Myeloma
      • New Diagnosis Tumor
      • BCMA CAR-T cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Jan 31, 2023

      Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

      Recruiting
      • Newly Diagnosed Peripheral T-cell Lymphoma
      • Duvelisib, Chidamide
      • Wuhan, Hubei, China
        Union Hospital, Tongji Medical College, Huazhong University of S
      Jul 27, 2023

      nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

      Recruiting
      • nk/T-cell Lymphoma
      • +2 more
      • XPO1 inhibitor
      • Beijing, Haidian, China
        ChinaPLAGH
      Apr 18, 2023

      Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)

      Active, not recruiting
      • Multiple Myeloma
      • Newly Diagnosed Patients
      • Torino, Italy
        Division of Hematology, AOU Città della Salute e della Scienza d
      Mar 24, 2022

      Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset), Diabetes, Type 1 Trial in Indianapolis (HAMS-AB, Placebo)

      Not yet recruiting
      • Type 1 Diabetes
      • +2 more
      • Indianapolis, Indiana
        Indiana School of Medicine
      Sep 28, 2023